- What are the tailwinds on the commercial battlefield for biotechs?
- How can you retain company culture right up to launch?
- How can smaller companies set themselves up to win against the biggest players?
While it is incredibly challenging to take a drug to market, some things have changed in biotechs’ favor.
What drives a decision to “go it alone” – and what are the steps to success?
Share:
In this webinar, our panel will look at the market landscape and biotechs’ growing role in launching novel products themselves. They’ll also highlight some of the successes that smaller players may want to emulate and consider the pitfalls to consider.
